Name
28bio
What We Do
28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today’s neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition. For more information, visit 28bio.com.
Website
Product or Service Categories (15)
Acute Toxicology, Biotechnology, Chemical Toxicology, Mechanistic Toxicology, Neurobiology/Neurotoxicology, Pharmaceutical Toxicology, Cells/Tissue, CRO—Contract Research Organization, In Vitro, Preclinical, Biomarkers, Efficacy Testing, High Throughput Test Systems, Modeling, Safety/Risk Assessment